PMC:3586680 / 0-289 JSONTXT 20 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T166 0-5 NN denotes Tumor
T167 6-16 NN denotes Suppressor
T168 17-21 NN denotes WWOX
T169 22-25 CC denotes and
T170 26-29 NN denotes p53
T171 30-41 NN denotes Alterations
T172 42-45 CC denotes and
T173 46-50 NNP denotes Drug
T174 51-61 NNP denotes Resistance
T175 62-64 IN denotes in
T176 65-78 NN denotes Glioblastomas
T177 89-94 NN denotes Tumor
T178 95-105 NN denotes suppressor
T179 106-109 NN denotes p53
T180 110-113 VB denotes are
T181 114-124 RB denotes frequently
T182 125-132 VB denotes mutated
T183 133-135 IN denotes in
T184 136-149 NN denotes glioblastomas
T185 150-151 -LRB- denotes (
T186 151-155 NN denotes GBMs
T187 155-156 -RRB- denotes )
T188 157-160 CC denotes and
T189 161-168 VB denotes appears
T190 169-171 TO denotes to
T191 172-182 VB denotes contribute
T192 182-183 -COMMA- denotes ,
T193 184-186 IN denotes in
T194 187-191 NN denotes part
T195 191-192 -COMMA- denotes ,
T196 193-195 TO denotes to
T197 196-206 NN denotes resistance
T198 207-209 TO denotes to
T199 210-222 NN denotes temozolomide
T200 223-224 -LRB- denotes (
T201 224-227 NN denotes TMZ
T202 227-228 -RRB- denotes )
T203 229-232 CC denotes and
T204 233-244 JJ denotes therapeutic
T205 245-250 NN denotes drugs
T206 252-254 JJ denotes WW
T207 255-272 JJ denotes domain-containing
T208 273-287 NN denotes oxidoreductase
R28 T168 T166 arg1Of WWOX,Tumor
R29 T168 T167 arg1Of WWOX,Suppressor
R30 T168 T169 arg1Of WWOX,and
R31 T169 T175 arg1Of and,in
R32 T171 T170 arg1Of Alterations,p53
R33 T171 T172 arg1Of Alterations,and
R34 T172 T169 arg2Of and,and
R35 T174 T172 arg2Of Resistance,and
R36 T174 T173 arg1Of Resistance,Drug
R37 T176 T175 arg2Of Glioblastomas,in
R38 T179 T177 arg1Of p53,Tumor
R39 T179 T178 arg1Of p53,suppressor
R40 T179 T180 arg1Of p53,are
R41 T179 T182 arg2Of p53,mutated
R42 T179 T189 arg1Of p53,appears
R43 T179 T191 arg1Of p53,contribute
R44 T182 T180 arg2Of mutated,are
R45 T182 T181 arg1Of mutated,frequently
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic